Related Experiment Video
Updated: Feb 25, 2026

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity
Published on: January 7, 2019
Sirt1 negatively regulates FcεRI-mediated mast cell activation through AMPK- and PTP1B-dependent processes
Xian Li1, Youn Ju Lee2, Fansi Jin1
1College of Pharmacy, Yeungnam University, 280 Daehak-Ro, Gyeongsan, Gyeongbuk, 38541, Republic of Korea.
Abstract:
Sirt1, a key regulator of metabolism and longevity, has recently been implicated in the regulation of allergic reactions, although the underlying mechanism remains unclear. Here we show that Sirt1 negatively regulates FcεRI-stimulated mast cell activation and anaphylaxis through two mutually regulated pathways involving AMP-activated protein kinase (AMPK) and protein tyrosine phosphatase 1B (PTP1B). Mast cell-specific knockout of Sirt1 dampened AMPK-dependent suppression of FcεRI signaling, thereby augmenting mast cell activation both in vitro and in vivo. Sirt1 inhibition of FcεRI signaling also involved an alternative component, PTP1B, which attenuated the inhibitory AMPK pathway and conversely enhanced the stimulatory Syk pathway, uncovering a novel role of this phosphatase. Moreover, a Sirt1 activator resveratrol stimulated the inhibitory AMPK axis, with reciprocal suppression of the stimulatory PTP1B/Syk axis, thus potently inhibiting anaphylaxis. Overall, our results provide a molecular explanation for the beneficial role of Sirt1 in allergy and underscore a potential application of Sirt1 activators as a new class of anti-allergic agents.
Insights
Sirtuin 1 (Sirt1) regulates allergic reactions by controlling mast cell activation. Activating Sirt1 with resveratrol inhibits anaphylaxis, suggesting its potential as an anti-allergy treatment.
Area of Science:
- Immunology
- Molecular Biology
- Metabolism
Background:
- Sirtuin 1 (Sirt1) is crucial for metabolism and longevity.
- Its role in allergic reactions is emerging but not fully understood.
- Mast cells are key players in allergic responses via FcεRI signaling.
Purpose of the Study:
- To elucidate the molecular mechanisms by which Sirt1 regulates mast cell activation and anaphylaxis.
- To investigate the involvement of AMP-activated protein kinase (AMPK) and protein tyrosine phosphatase 1B (PTP1B) in Sirt1-mediated allergic responses.
Main Methods:
- Mast cell-specific Sirt1 knockout mouse model.
- In vitro and in vivo studies of mast cell activation.
- Analysis of FcεRI signaling pathways, including AMPK, PTP1B, and Syk.
- Administration of Sirt1 activator resveratrol.
Main Results:
- Sirt1 deficiency in mast cells enhances FcεRI-stimulated activation and anaphylaxis.
- Sirt1 negatively regulates mast cell activation via both AMPK-dependent and PTP1B-dependent pathways.
- PTP1B attenuates AMPK signaling and enhances Syk signaling in the absence of Sirt1.
- Resveratrol activates Sirt1, suppresses PTP1B/Syk, and inhibits anaphylaxis.
Conclusions:
- Sirt1 acts as a negative regulator of mast cell activation and anaphylaxis.
- The findings reveal a novel mechanism involving Sirt1, AMPK, and PTP1B in allergy.
- Sirt1 activators like resveratrol show promise as novel anti-allergic agents.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
The JAK-STAT Signaling Pathway
Regulation of the Unfolded Protein Response
MAPK Signaling Cascades
cAMP-dependent Protein Kinase Pathways
TGF - β Signaling Pathway

